Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders

Guangming Zhang1, Huayuan Wei1, Anliu Zhao1

  • 1School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, No. 10, Poyang Lake Road, Tuanbo New City West District, Jinghai District, Tianjin, 301617, China.

PubMed

Insights

Mitochondrial DNA (mtDNA) leakage fuels neuroinflammation by activating immune sensors. Targeting mtDNA release offers a promising therapeutic strategy for neurological disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Mitochondrial dysfunction is a key driver of neuroinflammation.
  • Mitochondrial DNA (mtDNA) leakage acts as a critical intermediary in this process.
  • Escaped mtDNA triggers cytosolic DNA sensors, initiating inflammatory cascades.

Purpose of the Study:

  • To review the pathways of mtDNA release.
  • To elucidate the mechanisms by which leaked mtDNA induces neuroinflammation.
  • To discuss therapeutic strategies targeting mtDNA leakage.

Main Methods:

  • Literature review of studies on mtDNA release and neuroinflammation.
  • Analysis of signaling pathways involving cytosolic DNA sensors (e.g., cGAS) and inflammasomes.
  • Examination of mitochondrial dynamics and homeostasis.

Main Results:

  • Identified multiple pathways for mtDNA release, including membrane permeabilization and altered mitochondrial dynamics.
  • Demonstrated that leaked mtDNA activates cyclic GMP-AMP synthase (cGAS) and inflammasome pathways.
  • Established the link between mtDNA leakage, neuroinflammation, and neurological pathologies.

Conclusions:

  • mtDNA leakage is a central mechanism in neuroinflammation.
  • Therapeutic strategies should focus on preserving mtDNA homeostasis, preventing leakage, and inhibiting sensor activation.
  • Further research is crucial for developing precision therapies for neurological disorders.

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.4K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
7.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
436
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K